- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 211/30 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
Patent holdings for IPC class C07D 211/30
Total number of patents in this class: 53
10-year publication summary
2
|
2
|
1
|
2
|
3
|
1
|
0
|
0
|
1
|
0
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Theravance Biopharma R&D IP, LLC | 516 |
6 |
Prilenia Neurotherapeutics Ltd. | 88 |
4 |
Merck Patent GmbH | 5873 |
3 |
Ecolab USA Inc. | 5392 |
3 |
F. Hoffmann-La Roche AG | 7972 |
2 |
Genentech, Inc. | 3897 |
2 |
AstraZeneca AB | 2963 |
2 |
Constellation Pharmaceuticals, Inc. | 210 |
2 |
Nagoya Industrial Science Research Institute | 27 |
2 |
Nippon Zoki Pharmaceutical Co., Ltd. | 149 |
2 |
Merck Sharp & Dohme LLC | 3758 |
2 |
BASF SE | 20565 |
1 |
The Regents of the University of California | 19630 |
1 |
Janssen Pharmaceutica N.V. | 3589 |
1 |
Syngenta Crop Protection AG | 5246 |
1 |
The Board of Trustees of the Leland Stanford Junior University | 6287 |
1 |
Takeda Pharmaceutical Company Limited | 2938 |
1 |
The Chancellor, Masters and Scholars of The University of Oxford | 159 |
1 |
Genzyme Corporation | 1219 |
1 |
Global Blood Therapeutics, Inc. | 182 |
1 |
Other owners | 14 |